Linkedin Facebook Twitter Youtube

20 Jul RoslinCT

Posted at 16:32h in by

Barbara Ressler, Ph.D., Vice President, Manufacturing Process Sciences

Oct. 11 | 9:45am | Rentschler ATMP Ballroom 

Boston, MA

(Private)

RoslinCT is a leading global CDMO specializing in Advanced Cell and Gene Therapies. Founded in 2006, it leverages pioneering science from the cloning of Dolly the Sheep in 1997 to advance human medicine development. With a rich heritage, RoslinCT achieved notable milestones, including being one of the first to produce clinical-grade human pluripotent stem cells and supporting the development and future commercialization of cell therapies based on a broad range of cell types with an advanced program utilizing CRISPR-edited stem cell-based therapy. Operating 22 purpose-built cGMP cell therapy processing suites in Edinburgh, Scotland, and Hopkinton, Massachusetts, RoslinCT offers innovative process and analytical development, cGMP manufacturing, and iPSC cell line development, gene editing and differentiation. Their tailored CDMO solutions facilitate seamless progression from development to commercialization, delivering life-saving Cell and Gene Therapies globally.

www.roslinct.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 7-9, 2024
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions